HXBM
Price
$4.00
Change
-$1.00 (-20.00%)
Updated
Aug 11 closing price
Capitalization
898.83K
INTI
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
6.89M
Interact to see
Advertisement

HXBM vs INTI

Header iconHXBM vs INTI Comparison
Open Charts HXBM vs INTIBanner chart's image
Helix BioMedix
Price$4.00
Change-$1.00 (-20.00%)
Volume$188
Capitalization898.83K
Inhibitor Therapeutics
Price$0.04
Change-$0.00 (-0.00%)
Volume$162.52K
Capitalization6.89M
HXBM vs INTI Comparison Chart in %
Loading...
HXBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HXBM vs. INTI commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HXBM is a Hold and INTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (HXBM: $4.00 vs. INTI: $0.04)
Brand notoriety: HXBM and INTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HXBM: 136% vs. INTI: 1129%
Market capitalization -- HXBM: $898.83K vs. INTI: $6.89M
HXBM [@Biotechnology] is valued at $898.83K. INTI’s [@Biotechnology] market capitalization is $6.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HXBM’s FA Score shows that 1 FA rating(s) are green whileINTI’s FA Score has 0 green FA rating(s).

  • HXBM’s FA Score: 1 green, 4 red.
  • INTI’s FA Score: 0 green, 5 red.
According to our system of comparison, HXBM is a better buy in the long-term than INTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HXBM’s TA Score shows that 0 TA indicator(s) are bullish while INTI’s TA Score has 4 bullish TA indicator(s).

  • HXBM’s TA Score: 0 bullish, 5 bearish.
  • INTI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INTI is a better buy in the short-term than HXBM.

Price Growth

HXBM (@Biotechnology) experienced а -20.00% price change this week, while INTI (@Biotechnology) price change was -2.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INTI($6.89M) has a higher market cap than HXBM($899K). INTI YTD gains are higher at: -33.444 vs. HXBM (-50.000).
HXBMINTIHXBM / INTI
Capitalization899K6.89M13%
EBITDAN/A-3.56M-
Gain YTD-50.000-33.444150%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A4.32M-
Total DebtN/A84.3K-
FUNDAMENTALS RATINGS
HXBM vs INTI: Fundamental Ratings
HXBM
INTI
OUTLOOK RATING
1..100
9194
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9692
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HXBM's Valuation (5) in the null industry is somewhat better than the same rating for INTI (61). This means that HXBM’s stock grew somewhat faster than INTI’s over the last 12 months.

HXBM's Profit vs Risk Rating (100) in the null industry is in the same range as INTI (100). This means that HXBM’s stock grew similarly to INTI’s over the last 12 months.

HXBM's SMR Rating (98) in the null industry is in the same range as INTI (98). This means that HXBM’s stock grew similarly to INTI’s over the last 12 months.

INTI's Price Growth Rating (92) in the null industry is in the same range as HXBM (96). This means that INTI’s stock grew similarly to HXBM’s over the last 12 months.

INTI's P/E Growth Rating (88) in the null industry is in the same range as HXBM (100). This means that INTI’s stock grew similarly to HXBM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HXBMINTI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
31%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
18%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
33%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
19%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
HXBM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANGI18.300.13
+0.72%
Angi Inc
KVUE21.200.14
+0.66%
Kenvue
CNX28.790.07
+0.24%
CNX Resources Corp
PMTS15.61-0.11
-0.70%
CPI Card Group
AEHL3.49-0.08
-2.24%
Antelope Enterprise Holdings Limited

INTI and

Correlation & Price change

A.I.dvisor tells us that INTI and QRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTI and QRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
+2.30%
QRON - INTI
24%
Poorly correlated
N/A
DWTX - INTI
23%
Poorly correlated
+0.20%
IVEVF - INTI
17%
Poorly correlated
N/A
IVBXF - INTI
11%
Poorly correlated
-0.63%
ISCO - INTI
7%
Poorly correlated
N/A
More